Price$9.33+0.07 (+0.76%)
01:30 PM07:45 PM
News · 26 weeks360%
2026-03-012026-08-23
Mix1990d
- Insider7(37%)
- SEC Filings5(26%)
- Other3(16%)
- Analyst3(16%)
- Earnings1(5%)
Latest news
25 items- INSIDERGENERAL COUNSEL & CORP. SEC. Marshall Tyson Eliot sold $78,821 worth of shares (8,168 units at $9.65) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 630,398 units (SEC Form 4) (for tax liability)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- SECSEC Form 10-Q filed by Alphatec Holdings Inc.10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)
- SECSEC Form S-8 filed by Alphatec Holdings Inc.S-8 - Alphatec Holdings, Inc. (0001350653) (Filer)
- SECAlphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Alphatec Holdings, Inc. (0001350653) (Filer)
- PRATEC Reports Second Quarter Financial ResultsTotal revenue of $214 million, up 15% year-over-year Surgical revenue of $196 million increased 17%, driven by 20% case volume growth Company reaffirms 2026 revenue outlook Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2026, and business highlights. Second Quarter 2026 Financial Results Quarter Ended June 30, 2026 Total revenue $214 million GAAP gross margin 72.2% Non-GAAP gross margin 72.5% GAAP operating expenses $156 million Non-GAAP operating
- ANALYSTUBS initiated coverage on Alphatec with a new price targetUBS initiated coverage of Alphatec with a rating of Buy and set a new price target of $15.00
- PRATEC Announces Participation in Upcoming Investor ConferencesAlphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Diagnostics California Bus Tour on Wednesday, August 19, 2026, at 9:45 a.m. PT at The Ritz-Carlton Laguna Niguel. Management will host one-on-one investor meetings and participate in a fireside chat at the 2026 Wells Fargo Healthcar
- ANALYSTStephens initiated coverage on Alphatec with a new price targetStephens initiated coverage of Alphatec with a rating of Overweight and set a new price target of $15.00
- PRATEC to Report Second Quarter 2026 Financial Results on August 4, 2026Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC’s corporate website.Analyst ParticipationTo participate in the question-and-answer session, analysts must register in advance using this link. Upon registration, access details, including a unique code, will be provided via email.ReplayA replay
- ANALYSTBMO Capital Markets initiated coverage on Alphatec with a new price targetBMO Capital Markets initiated coverage of Alphatec with a rating of Outperform and set a new price target of $11.00
- INSIDERDirector Mcginnis Karen K was granted 32,012 shares and sold $48,460 worth of shares (6,050 units at $8.01) as part of a pre-agreed trading plan, increasing direct ownership by 38% to 94,671 units (SEC Form 4) to cover withholding tax4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- INSIDERDirector Blackford Quentin S. was granted 32,012 shares, increasing direct ownership by 6% to 600,381 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- INSIDERDirector Valentine Keith was granted 32,012 shares, increasing direct ownership by 14% to 264,283 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- INSIDERDirector Pelizzon David R was granted 32,012 shares, increasing direct ownership by 9% to 378,839 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- INSIDERDirector Berkowitz Mortimer Iii was granted 32,012 shares, increasing direct ownership by 5% to 650,062 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- INSIDERDirector Demski David M was granted 32,012 shares, increasing direct ownership by 8% to 431,635 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- SECSEC Form S-8 filed by Alphatec Holdings Inc.S-8 - Alphatec Holdings, Inc. (0001350653) (Filer)
- SECSEC Form 144 filed by Alphatec Holdings Inc.144 - Alphatec Holdings, Inc. (0001350653) (Subject)
- SECSEC Form SD filed by Alphatec Holdings Inc.SD - Alphatec Holdings, Inc. (0001350653) (Filer)
- INSIDERDirector Valentine Keith bought $996,192 worth of shares (135,000 units at $7.38), increasing direct ownership by 139% to 232,271 units (SEC Form 4)4 - Alphatec Holdings, Inc. (0001350653) (Issuer)
- SECSEC Form 10-Q filed by Alphatec Holdings Inc.10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)
- SECAlphatec Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Alphatec Holdings, Inc. (0001350653) (Filer)
- PRATEC Refinances Existing Debt with Inaugural Bank FacilityAlphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced it has entered into a new credit facility, including a $125 million revolving credit facility and $175 million Term Loan A, led by JPMorgan Chase Bank, N.A. and TD Securities (USA) LLC. This transaction represents ATEC's inaugural syndicated bank facility and reflects the Company's strong operating performance and continued progression to a more scaled and profitable financial profile. The new facility refinances the Company's existing debt, including its prior term loan and asset-based lending facilities with Braidwell LP, Pha
- PRATEC Reports First Quarter Financial ResultsSurgical revenue grew 17%; total revenue grew 14% Company announces refinancing of existing debt with inaugural bank facility, reducing interest expense by more than $6 million annually and extending maturities to 2031 Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2026, and business highlights. First Quarter 2026 Financial Results Quarter Ended March 31, 2026 Total revenue $192 million GAAP gross margin 71% Non-GAAP gross margin 72% GAAP operating expenses
- SECSEC Form DEFA14A filed by Alphatec Holdings Inc.DEFA14A - Alphatec Holdings, Inc. (0001350653) (Filer)
ATEC FAQ
7 questionsWhat does Alphatec Holdings Inc. do?
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar...Where does ATEC stock trade?
Alphatec Holdings Inc. (ATEC) is listed on NASDAQ.What sector and industry is ATEC in?
Alphatec Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Alphatec Holdings Inc. go public?
Alphatec Holdings Inc. (ATEC) completed its IPO in 2006.What are analysts saying about ATEC?
Alphatec Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Buy with a $1500.00 price target on 2026-07-28. Recent price targets range from $1100.00 to $2000.00.What companies are similar to ATEC?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare ATEC side-by-side with any of them on Quantisnow.How can I track ATEC on Quantisnow?
Quantisnow aggregates Alphatec Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ATEC to receive live email and push alerts on every new disclosure.